Patents by Inventor Nancy Noble

Nancy Noble has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF INHIBITING FIBROSIS USING ANTI-PAI-1 ANTIBODIES
    Publication number: 20130266566
    Abstract: Provided are anti-PAI-1 antibodies or antibody fragments and methods of using them.
    Type: Application
    Filed: March 21, 2013
    Publication date: October 10, 2013
    Applicant: Abbott Laboratories
    Inventors: Ian Anderson, Anthony Coyle, Nancy Noble
  • Methods for treating conditions associated with the accumulation of excess extracellular matrix
    Publication number: 20050124534
    Abstract: The present invention is methods and compositions for reducing and preventing the excess accumulation of extracellular matrix in a tissue and/or organ or at a wound site using a combination of agents that inhibit TGF?, or using agents that inhibit TGF? in combination with agents that degrade excess accumulated extracellular matrix, or at least one agent that degrades excess accumulated extracellular matrix. The compositions and methods of the invention are used to treat conditions such as fibrotic diseases and scarring that result from excess accumulation of extracellular matrix, impairing tissue or organ function or skin appearance in a subject.
    Type: Application
    Filed: September 27, 2004
    Publication date: June 9, 2005
    Inventors: Nancy Noble, Wayne Border
  • Methods for treating conditions associated with the accumulation of excess extracellular matrix
    Publication number: 20050037007
    Abstract: The present invention is methods and compositions for reducing and preventing the excess accumulation of extracellular matrix in a tissue and/or organ or at a wound site using a combination of agents that inhibit TGF?, or using agents that inhibit TGF? in combination with agents that degrade excess accumulated extracellular matrix. The compositions and methods of the invention are used to treat conditions such as fibrotic diseases and scarring that result from excess accumulation of extracellular matrix, impairing tissue or organ function or skin appearance in a subject.
    Type: Application
    Filed: July 8, 2004
    Publication date: February 17, 2005
    Inventors: Nancy Noble, Wayne Border, Daniel Lawrence